Physician profile
Paula Eboli
NPI 1043413438
$4,244.90
in general payments reported to CMS, 2019-2025
46 companies · $1,609 in 2025
The $1,609 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2020: $173 · 2021: $264 · 2022: $392 · 2023: $441 · 2024: $377 · 2025: $1,609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410 · Travel and Lodging: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.24 |
| Travel and Lodging | $1,017.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,318.80 | 2025 | Azurion 7 B20 |
| Medtronic USA, INC. | $382.70 | 2019 | |
| Lilly USA, LLC | $241.42 | 2019-2024 | Amyvid |
| Csl Behring | $198.55 | 2019-2024 | Hizentra |
| Amgen INC. | $170.92 | 2019-2022 | |
| Boston Scientific Corporation | $144.86 | 2024 | |
| Abbvie INC. | $131.94 | 2023-2025 | Botox, Ubrelvy |
| Ucb, INC. | $124.97 | 2021-2025 | Briviact, Nayzilam |
| Janssen Pharmaceuticals, INC | $113.81 | 2019 | |
| Imperative Care, INC | $107.14 | 2023 | Zoom 88-T Large Distal Platform |
| Lundbeck LLC | $88.62 | 2021-2025 | Vyepti |
| Medtronic, INC. | $76.95 | 2022-2024 | Solitaire X |
| Acorda Therapeutics, INC | $71.11 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $65.84 | 2022-2024 | Ultomiris, Soliris |
| Alnylam Pharmaceuticals INC. | $63.02 | 2022-2024 | Amvuttra |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Eboli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.